Uni-Bio Science Group Limited (HKG:0690)
Hong Kong · Delayed Price · Currency is HKD 0.0660
0.00 (0.00%)
Nov 3, 2026, 3:41 PM HKT
Uni-Bio Science Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 394 | 687 | 358 | 452 | 458 | 533 | |
Market Cap Growth | -48.03% | 91.67% | -20.75% | -1.35% | -14.08% | -27.43% |
Enterprise Value | 304 | 606 | 272 | 363 | 366 | 435 |
Last Close Price | 0.07 | 0.11 | 0.06 | 0.07 | 0.07 | 0.08 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.15 | 7.36 | 4.33 | 6.38 | 11.90 | - |
PS Ratio | 0.72 | 1.17 | 0.65 | 0.93 | 1.04 | 1.51 |
PB Ratio | 0.88 | 1.66 | 1.10 | 1.76 | 2.35 | 3.06 |
P/TBV Ratio | 0.88 | 1.67 | 1.11 | 1.78 | 2.39 | 3.13 |
P/FCF Ratio | - | 18.78 | 12.48 | 11.56 | 22.65 | 147.83 |
P/OCF Ratio | 9.40 | 7.73 | 5.37 | 4.57 | 9.42 | 44.29 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.55 | 1.03 | 0.49 | 0.75 | 0.83 | 1.23 |
EV/EBITDA Ratio | 3.97 | 5.60 | 2.42 | 3.93 | 6.14 | 39.96 |
EV/EBIT Ratio | 5.39 | 6.23 | 2.73 | 4.49 | 7.74 | - |
EV/FCF Ratio | - | 16.58 | 9.46 | 9.29 | 18.08 | 120.49 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.20 | 0.25 | 0.37 | 0.24 | 0.12 | 0.03 |
Debt / EBITDA Ratio | 1.19 | 0.90 | 1.03 | 0.63 | 0.35 | 0.36 |
Debt / FCF Ratio | - | 2.82 | 4.20 | 1.58 | 1.13 | 1.55 |
Net Debt / Equity Ratio | -0.20 | -0.20 | -0.16 | -0.31 | -0.44 | -0.49 |
Net Debt / EBITDA Ratio | -1.30 | -0.78 | -0.48 | -0.86 | -1.44 | -7.79 |
Net Debt / FCF Ratio | 8.77 | -2.32 | -1.87 | -2.04 | -4.24 | -23.48 |
Asset Turnover | 0.95 | 1.07 | 1.19 | 1.38 | 1.57 | 1.36 |
Inventory Turnover | 2.95 | 2.79 | 2.62 | 2.62 | 2.87 | 2.72 |
Quick Ratio | 2.47 | 2.68 | 1.97 | 1.70 | 1.85 | 1.76 |
Current Ratio | 2.93 | 3.23 | 2.58 | 2.07 | 2.22 | 2.19 |
Return on Equity (ROE) | 11.68% | 25.26% | 28.41% | 31.37% | 20.87% | -10.77% |
Return on Assets (ROA) | 6.03% | 11.07% | 13.43% | 14.39% | 10.54% | -1.16% |
Return on Invested Capital (ROIC) | 12.61% | 29.77% | 40.27% | 52.77% | 42.34% | -4.70% |
Return on Capital Employed (ROCE) | 11.50% | 20.40% | 25.30% | 27.40% | 23.40% | -2.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 12.27% | 13.59% | 23.10% | 15.68% | 8.40% | -3.67% |
FCF Yield | -2.62% | 5.33% | 8.01% | 8.65% | 4.41% | 0.68% |
Dividend Yield | 4.74% | 2.72% | 4.62% | - | - | - |
Buyback Yield / Dilution | 1.20% | 2.75% | 3.53% | -0.07% | 0.17% | 0.57% |
Total Shareholder Return | 5.95% | 5.47% | 8.15% | -0.07% | 0.17% | 0.57% |